Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jan
4
2021
NBA Star Michael Jordan Wins Huge Chinese Victory Against Qiaodan (Jordan) Sports Over Misuse of His Name Schwegman, Lundberg & Woessner, P.A.
Oct
21
2014
Patent Board Denies First Data Corp. IPR Petitions Based on Real Party In Interest and One-Year Bar Schwegman, Lundberg & Woessner, P.A.
Mar
25
2021
China Releases Patent Office Budget Indicating Expected Potential Decline in Future Patent Application Filings as China Transitions from Quantity to Quality Schwegman, Lundberg & Woessner, P.A.
Apr
24
2021
Director of China’s National Intellectual Property Administration: Speed Up Patent & TM Prosecution; Crack Down on Irregular Applications Schwegman, Lundberg & Woessner, P.A.
May
8
2021
China Utility Model Patent Application Filings Up 29% in 2020; Foreign-Originated Chinese Invention Patent Application Filings Down 3% Schwegman, Lundberg & Woessner, P.A.
Dec
19
2014
Cooler Heads Prevail in New Interim Guidance on Patent Subject Matter Eligibility Schwegman, Lundberg & Woessner, P.A.
Jul
19
2017
Millennium Pharm. v. Sandoz, Inc. – Revenge of the Chemical Judges Schwegman, Lundberg & Woessner, P.A.
Jun
10
2021
Foreigners Can Now Take the Chinese Patent Bar Examination Schwegman, Lundberg & Woessner, P.A.
Sep
18
2021
China’s National People’s Congress Releases Translation of the Amended Copyright Law Schwegman, Lundberg & Woessner, P.A.
Mar
11
2015
Takeaways from Chisum Patent Academy 2015 Seminar in Cincinnati Schwegman, Lundberg & Woessner, P.A.
Mar
19
2015
Enzo Biochem V. Applera Corp. – When “Words Can Hurt You” Schwegman, Lundberg & Woessner, P.A.
Oct
23
2021
China’s Shanghai Pudong Court Sentences 69 Defendants for Counterfeiting Chanel, Cartier and Gucci Products for up to 5 Years 9 Months with a $1.8 Million USD Fine Schwegman, Lundberg & Woessner, P.A.
Oct
29
2021
China Releases 14th Five-Year Plan Notice on Intellectual Property – China to More than Double Number of Foreign Patents by 2025 Schwegman, Lundberg & Woessner, P.A.
Dec
2
2021
Indivior v. Dr. Reddy’s Laboratory – Homeless on the Range Schwegman, Lundberg & Woessner, P.A.
Apr
2
2011
One Step Towards an EJC Decision on the Patentability of Embryonic Stem Cells in Europe Schwegman, Lundberg & Woessner, P.A.
Apr
13
2011
Fixing The Holes – Proposed Patent Reform Bill Amendment De-Bugs Grace Period Schwegman, Lundberg & Woessner, P.A.
Jan
9
2022
Chinese Invention Patent and Utility Model Grants Both Up 31% in 2021 Schwegman, Lundberg & Woessner, P.A.
May
6
2011
Oracle Ordered to Reduce the Number of Patent Infringement Claims against Google Schwegman, Lundberg & Woessner, P.A.
Jun
23
2011
Supreme Court Grants Cert. In Mayo v. Prometheus Schwegman, Lundberg & Woessner, P.A.
Apr
23
2022
China Releases Several Provisions of the Supreme People’s Court on Jurisdiction of Intellectual Property Cases of First Instance Schwegman, Lundberg & Woessner, P.A.
Jun
6
2022
China’s National Intellectual Property Administration Issues 2021 Annual Report: Invention Patent Application Filings Reached 1.586 Million! Schwegman, Lundberg & Woessner, P.A.
Feb
28
2012
Bayer v. Lupin – Patenting The Label Redux Schwegman, Lundberg & Woessner, P.A.
Jul
9
2015
Intellectual Ventures I v. Capitol One Bank: Mental Steps Doctrine Making Strong Comeback, Courtesy of Alice Schwegman, Lundberg & Woessner, P.A.
Mar
29
2012
Legal Challenge To “ObamaCare” Threatens Generic Biologicals Schwegman, Lundberg & Woessner, P.A.
Aug
19
2015
Takeaways from Seattle Chisum Patent Academy 2015 Seminars Schwegman, Lundberg & Woessner, P.A.
Oct
30
2022
China to Add Statement of Use Requirement for Trademarks? Schwegman, Lundberg & Woessner, P.A.
Nov
21
2022
China’s Supreme People’s Court Releases Draft Judicial Interpretation of Anti-Monopoly Civil Procedures for Comment Schwegman, Lundberg & Woessner, P.A.
Dec
1
2022
NetEase Wins 50 Million RMB & Injunction on Appeal in Minecraft Infringement Litigation at the Guangdong Higher People’s Court Schwegman, Lundberg & Woessner, P.A.
Oct
11
2012
Federal Circuit to Address Computer-Implemented Inventions En Banc Schwegman, Lundberg & Woessner, P.A.
Jan
16
2023
Chinese Invention Patent Grants Up 14.7% in 2022 YoY; Utility Model Grants Down 10.1% Schwegman, Lundberg & Woessner, P.A.
Feb
17
2023
Mattel Defeats Chinese Trademark Applicant Attempting to Register “Barbie” for Services Including Artificial Insemination (For Animals) Schwegman, Lundberg & Woessner, P.A.
Dec
21
2012
In re Rosuvastatin Calcium Patent Litigation – Making “Therasense” out of Confusion Schwegman, Lundberg & Woessner, P.A.
Oct
14
2015
Takeaways from Chisum’s Washington, D.C. September 2015 Seminar Schwegman, Lundberg & Woessner, P.A.
Jan
28
2013
Amazon Loses Gift Patent in European Patent Office "EPO" Opposition Schwegman, Lundberg & Woessner, P.A.
Feb
5
2013
Time For Myriad To Fight Another Day - DNA Composition Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins